![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1520647
¼¼°èÀÇ ¾Ë·¹¸£±â Áø´Ü ½ÃÀå ±Ô¸ð Á¶»ç : Á¦Ç° ¹× ¼ºñ½ºº°, °Ë»ç À¯Çüº°, ¾Ë·¹¸£°Õº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Allergy Diagnostics Market Size Study, by Product & Service, by Test Type, by Allergen, by End User and Regional Forecasts 2022-2032 |
¼¼°è ¾Ë·¹¸£±â Áø´Ü ½ÃÀåÀº 2023³â ¾à 59¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö 11.4% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾Ë·¹¸£±â Áø´ÜÇÐÀº °³ÀÎÀÇ ¾Ë·¹¸£±â ¹ÝÀÀÀ» È®ÀÎÇÏ°í ºÐ¼®ÇÏ´Â °ÍÀ» Àü¹®À¸·Î ÇÏ´Â ÀÇÇÐÀÇ ÇÑ ºÐ¾ßÀÔ´Ï´Ù. ȯÀÚÀÇ ¾Ë·¹¸£±â ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ƯÁ¤ ¾Ë·¹¸£°ÕÀ» Á¤È®È÷ ã¾Æ³»´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ´Ù¾çÇÑ °Ë»ç¿Í ÀýÂ÷°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Áø´Ü ¹æ¹ý¿¡´Â ÇǺΠµµ¸» °Ë»ç, Ç÷¾× °Ë»ç, ÆÐÄ¡ Å×½ºÆ®, °æ±¸ À½½Ä¹° °Ë»ç µîÀÌ Æ÷ÇԵ˴ϴÙ. ºÎÀÛ¿ëÀ» À¯¹ßÇÏ´Â ¾Ë·¹¸£°ÕÀ» Á¤È®È÷ ÆÄ¾ÇÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡´Â ȯÀÚÀÇ ¾Ë·¹¸£±â¸¦ °ü¸®Çϱâ À§ÇÑ È¿°úÀûÀÎ Ä¡·á °èȹ°ú Àü·«À» ¼ö¸³ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾Ë·¹¸£±â Áø´ÜÀº ¾Ë·¹¸£±â ÁúȯÀÇ Áø´Ü°ú °ü¸®¸¦ ¿ëÀÌÇÏ°Ô Çϰí ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µî °Ç°°ü¸®¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.
¾Ë·¹¸£±â Áø´Ü ½ÃÀåÀº ¼¼°è ¾Ë·¹¸£±â ÁúȯÀÇ À¯º´·ü Áõ°¡, Áø´Ü ±â¼úÀÇ ±â¼úÀû Áøº¸, °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× Ç¥Àû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀå ÀáÀç·ÂÀÌ ³ôÀº ½ÃÀåÀÔ´Ï´Ù. ¶ÇÇÑ, ¾Ë·¹¸£±â Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í, ½ÅÈï±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ È®ÃæµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Ë·¹¸£±â Áø´Ü ±â±âÀÇ ³ôÀº ºñ¿ë°ú Áø´Ü Á¦Ç° ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Ë·¹¸£±â Áø´Ü¿¡ ÀΰøÁö´ÉÀÇ ÅëÇÕ°ú ¼Ò¸Å ¾à±¹¿¡¼ÀÇ ¾Ë·¹¸£±â °Ë»ç ¼ºñ½º È®´ë´Â ½ÃÀå ¼ºÀåÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.
Áø´Ü ½ÇÇè½Ç ºÎ¹®Àº ´Ù¾çÇÑ ¾Ë·¹¸£±â °Ë»ç¸¦ ¼öÇàÇÒ ¼ö Àִ ÷´Ü Àåºñ¿Í ¼÷·ÃµÈ ÀηÂÀ» °®Ãá Áß¾Ó ÁýÁᫎ ½Ã¼³À» ÀÌ¿ëÇÒ ¼ö Àֱ⠶§¹®¿¡ ½ÃÀå Á¡À¯À²À» Àå¾ÇÇÏ°í ¿¹Ãø ±â°£ µ¿¾È ¼±µÎ¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ȯÀÚµéÀº ¾Ë·¹¸£±â °ü·Ã ¹®Á¦¿¡ ´ëÇØ Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ ¾ò±â À§ÇØ ÀÌ·¯ÇÑ °Ë»ç ±â°ü¿¡ ÀÇÁ¸ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ, Áø´Ü °Ë»ç ±â°üÀº ±¤¹üÀ§ÇÑ ¾Ë·¹¸£±â Ç׿øÀ» Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ¾Ë·¹¸£±â °Ë»ç ÆÐ³ÎÀ» Á¦°øÇÏ¿© ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü°¡ ƯÁ¤ À¯¹ß ¿äÀÎÀ» È¿°úÀûÀ¸·Î ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î ¾Ë·¹¸£±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾Ë·¹¸£±â °Ë»ç ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, À̴ ȯÀÚµéÀÌ Áø´Ü ½ÇÇè½Ç¿¡¼ Áø´Ü ¹× Ä¡·á¸¦ ¹ÞÀ¸·Á´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼ú ¹ßÀüÀ¸·Î Áø´Ü ½ÇÇè½ÇÀÇ ¿ª·®ÀÌ Çâ»óµÇ¾î Á¤È®¼º°ú È¿À²¼ºÀÌ Çâ»óµÈ Çõ½ÅÀûÀÎ ¾Ë·¹¸£±â Áø´Ü °Ë»ç¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î Áø´Ü°Ë»ç½Ç ºÎ¹®Àº ȯÀڵ鿡°Ô Á¢±ÙÀÌ ¿ëÀÌÇϰí Á¾ÇÕÀûÀÌ¸ç ½Å·ÚÇÒ ¼ö ÀÖ´Â °Ë»ç ¼ºñ½º¸¦ Á¦°øÇÔÀ¸·Î½á ¾Ë·¹¸£±â Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â ¾Ë·¹¸£±â¼º ºñ¿°ÀÇ À¯º´·ü Áõ°¡¿Í ÇÔ²² Áö¿ª Àü¹Ý¿¡ °ÉÃÄ ÀûÀýÇÑ Áø´Ü ¹æ¹ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾Ë·¹¸£±â Áø´ÜÀÇ ÁÖ¿ä ½ÃÀåÀ¸·Î ¼±µÎ¸¦ ´Þ¸®°í ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ¾÷°è¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³â¿¡´Â ¹Ì±¹ÀÌ ºÏ¹Ì ½ÃÀå¿¡¼ ¿ìÀ§¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î °ÇÀüÇÑ ¼ºÀåÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ¿äÀÎÀ¸·Î´Â ¾çÈ£ÇÑ ¼öÀÍ ½Ã³ª¸®¿À, Çõ½ÅÀûÀÎ Á¦Ç° Ãâ½Ã¸¦ ÃËÁøÇÏ´Â ¾Ë·¹¸£±â Áø´Ü ±â¾÷¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡, ½Å¼ÓÇÑ Áø´Ü Å×½ºÆ® ŰƮ¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹¿¡¼´Â ½Äǰ ¹× ÇǺΠ°ü·Ã ¾Ë·¹¸£±â°¡ ÀÖ´Â Àα¸°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
The Global Allergy Diagnostics Market is valued at approximately USD 5.96 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.4% over the forecast period 2024-2032. Allergy diagnostics is the branch of medical science dedicated to identifying and analysing allergic reactions in individuals. It encompasses a variety of tests and procedures aimed at pinpointing specific allergens that trigger allergic responses in patients. These diagnostic methods may include skin prick tests, blood tests, patch tests, and oral food challenges, among others. By accurately identifying the allergens causing adverse reactions, healthcare professionals can devise effective treatment plans and strategies for managing allergies in patients. Allergy diagnostics play a crucial role in healthcare, facilitating the diagnosis and management of allergic conditions to improve patients' quality of life.
The allergy diagnostics market holds promising growth potential due to several factors, including the increasing prevalence of allergic diseases worldwide, technological advancements in diagnostic techniques, and growing demand for personalized medicine and targeted therapy. Additionally, rising awareness about early diagnosis and treatment of allergies and expansion of healthcare infrastructure in emerging economies are the prominent factors driving the growth of the market. However, high costs of allergy diagnostic instruments and stringent regulatory requirements for approval of diagnostic products are restraining the market growth. On the contrary, the integration of artificial intelligence in allergy diagnostics and the expansion of allergy testing services in retail pharmacies are creating opportunities for market growth.
The diagnostic laboratories segment dominated the market share and is expected to maintain its leading position throughout the forecast period owing to the availability of centralized facilities equipped with advanced equipment and trained personnel capable of conducting a wide range of allergy tests. Patients often rely on these laboratories to obtain accurate and reliable results for their allergy-related concerns. Additionally, diagnostic laboratories offer comprehensive allergy testing panels that cover a broad spectrum of allergens, allowing healthcare providers to identify specific triggers effectively. Moreover, the increasing prevalence of allergic diseases worldwide has led to a surge in demand for allergy testing services, driving patients to seek diagnosis and treatment in diagnostic laboratories. Furthermore, advancements in technology have enhanced the capabilities of diagnostic laboratories, enabling them to offer innovative allergy diagnostic tests with improved accuracy and efficiency. Overall, the diagnostic laboratories segment plays a crucial role in meeting the growing demand for allergy diagnostics by providing accessible, comprehensive, and reliable testing services to patients.
North America leads as the primary market for allergy diagnostics, holding the largest share in the industry during the forecast period due to the rising prevalence of allergic rhinitis, coupled with increased awareness of proper diagnostic procedures across the region. In 2022, the U.S. asserted its dominance within the North America market and is anticipated to sustain healthy growth with the highest CAGR throughout the analysis period. Factors contributing to this trend include a favorable return scenario, heightened funding for allergy diagnostic companies facilitating innovative product launches, and a surge in demand for rapid diagnostic test kits. Additionally, the U.S. witnesses a consistent increase in the population with food and skin-related allergies.